Gap Valuation
Is GAP1 * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of GAP1 * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: GAP1 * (MX$453.61) is trading below our estimate of fair value (MX$705.51)
Significantly Below Fair Value: GAP1 * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for GAP1 *?
Other financial metrics that can be useful for relative valuation.
What is GAP1 *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$8.73b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.8x |
Enterprise Value/EBITDA | 9.5x |
PEG Ratio | 1.8x |
Price to Earnings Ratio vs Peers
How does GAP1 *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 12.4x | ||
LIVEPOL C-1 El Puerto de Liverpool. de | 7.2x | 5.5% | Mex$170.8b |
GIGANTE * Grupo Gigante S. A. B. de C. V | 12.8x | n/a | Mex$23.9b |
GSANBOR B-1 Grupo Sanborns. de | 12.8x | n/a | Mex$58.4b |
ANF Abercrombie & Fitch | 16.6x | 7.9% | US$8.5b |
GAP1 * Gap | 12.4x | 6.9% | Mex$8.7b |
Price-To-Earnings vs Peers: GAP1 * is expensive based on its Price-To-Earnings Ratio (12.4x) compared to the peer average (12.2x).
Price to Earnings Ratio vs Industry
How does GAP1 *'s PE Ratio compare vs other companies in the Global Specialty Retail Industry?
Price-To-Earnings vs Industry: GAP1 * is good value based on its Price-To-Earnings Ratio (12.4x) compared to the Global Specialty Retail industry average (16.1x).
Price to Earnings Ratio vs Fair Ratio
What is GAP1 *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 12.4x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate GAP1 *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$453.61 | Mex$546.99 +20.6% | 17.3% | Mex$677.88 | Mex$251.78 | n/a | 19 |
Aug ’25 | n/a | Mex$526.94 0% | 17.1% | Mex$652.05 | Mex$242.19 | n/a | 19 |
Jul ’25 | Mex$446.92 | Mex$498.36 +11.5% | 19.6% | Mex$634.90 | Mex$235.82 | n/a | 20 |
Jun ’25 | Mex$492.00 | Mex$451.25 -8.3% | 23.2% | Mex$593.80 | Mex$152.69 | n/a | 20 |
May ’25 | n/a | Mex$372.30 0% | 21.4% | Mex$550.76 | Mex$154.90 | n/a | 21 |
Apr ’25 | Mex$469.00 | Mex$359.56 -23.3% | 21.3% | Mex$533.09 | Mex$149.93 | n/a | 21 |
Mar ’25 | Mex$335.00 | Mex$329.54 -1.6% | 23.7% | Mex$444.45 | Mex$136.75 | n/a | 20 |
Feb ’25 | Mex$339.00 | Mex$316.63 -6.6% | 26.4% | Mex$446.13 | Mex$137.27 | n/a | 20 |
Jan ’25 | Mex$355.00 | Mex$289.97 -18.3% | 24.9% | Mex$422.81 | Mex$135.30 | n/a | 21 |
Dec ’24 | Mex$360.00 | Mex$276.65 -23.2% | 22.8% | Mex$403.80 | Mex$137.46 | n/a | 20 |
Nov ’24 | Mex$240.00 | Mex$217.07 -9.6% | 32.2% | Mex$423.70 | Mex$108.18 | n/a | 19 |
Oct ’24 | Mex$185.00 | Mex$200.57 +8.4% | 31.7% | Mex$413.91 | Mex$105.68 | n/a | 20 |
Sep ’24 | Mex$200.00 | Mex$190.31 -4.8% | 31.9% | Mex$394.64 | Mex$100.76 | n/a | 20 |
Aug ’24 | Mex$176.00 | Mex$186.91 +6.2% | 34.3% | Mex$396.24 | Mex$101.17 | n/a | 20 |
Jul ’24 | n/a | Mex$187.33 0% | 34.9% | Mex$404.44 | Mex$103.26 | Mex$446.92 | 20 |
Jun ’24 | Mex$140.00 | Mex$196.16 +40.1% | 36.1% | Mex$415.68 | Mex$106.13 | Mex$492.00 | 20 |
May ’24 | Mex$170.00 | Mex$219.66 +29.2% | 31.9% | Mex$424.12 | Mex$126.33 | n/a | 19 |
Apr ’24 | Mex$164.00 | Mex$222.39 +35.6% | 31.7% | Mex$425.18 | Mex$126.65 | Mex$469.00 | 18 |
Mar ’24 | n/a | Mex$236.18 0% | 32.4% | Mex$460.25 | Mex$128.87 | Mex$335.00 | 19 |
Feb ’24 | Mex$245.00 | Mex$237.84 -2.9% | 33.9% | Mex$471.21 | Mex$131.94 | Mex$339.00 | 19 |
Jan ’24 | Mex$220.00 | Mex$256.84 +16.7% | 31.5% | Mex$496.45 | Mex$139.00 | Mex$355.00 | 19 |
Dec ’23 | Mex$277.00 | Mex$239.70 -13.5% | 31.5% | Mex$478.89 | Mex$134.09 | Mex$360.00 | 19 |
Nov ’23 | Mex$226.20 | Mex$209.85 -7.2% | 38.6% | Mex$504.33 | Mex$141.21 | Mex$240.00 | 20 |
Oct ’23 | Mex$165.00 | Mex$209.85 +27.2% | 38.6% | Mex$504.33 | Mex$141.21 | Mex$185.00 | 20 |
Sep ’23 | Mex$185.00 | Mex$208.17 +12.5% | 41.0% | Mex$524.84 | Mex$141.30 | Mex$200.00 | 20 |
Aug ’23 | Mex$193.00 | Mex$201.24 +4.3% | 45.2% | Mex$534.03 | Mex$102.70 | Mex$176.00 | 21 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.